PRECIPIO, INC. Gain (Loss) on Derivative Instruments Held for Trading Purposes, Net
PRECIPIO, INC. (PRPO) reported Gain (Loss) on Derivative Instruments Held for Trading Purposes, Net of -$415.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2021-03-29.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet · last filed 2021-03-29
- PRECIPIO, INC. gain (loss) on derivative instruments held for trading purposes, net for the quarter ending 2019-12-31 was $0.00, a 100.00% decline year-over-year.
- PRECIPIO, INC. gain (loss) on derivative instruments held for trading purposes, net for the quarter ending 2019-09-30 was $0.00, a 100.00% decline year-over-year.
- PRECIPIO, INC. gain (loss) on derivative instruments held for trading purposes, net for the quarter ending 2019-06-30 was -$438.00K.
- PRECIPIO, INC. gain (loss) on derivative instruments held for trading purposes, net for the quarter ending 2019-03-31 was $23.00K.
- PRECIPIO, INC. gain (loss) on derivative instruments held for trading purposes, net for fiscal 2019 was -$415.00K, a 255.43% decline from fiscal 2018.
- PRECIPIO, INC. gain (loss) on derivative instruments held for trading purposes, net for fiscal 2018 was $267.00K.
| Period end | Gain (Loss) on Derivative Instruments Held for Trading Purposes, Net 3 month | Gain (Loss) on Derivative Instruments Held for Trading Purposes, Net 6 month | Gain (Loss) on Derivative Instruments Held for Trading Purposes, Net 9 month | Gain (Loss) on Derivative Instruments Held for Trading Purposes, Net 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $0.00 derived: sum of 2 quarters · filed 2021-03-29 | -$438.00K derived: sum of 3 quarters · filed 2021-03-29 | -$415.00K 10-K · filed 2021-03-29 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | -$438.00K derived: sum of 2 quarters · filed 2020-11-13 | -$415.00K 10-Q · filed 2020-11-13 | -$264.00K derived: sum of 4 quarters · filed 2020-11-13 |
| 2019-06-30 | -$438.00K 10-Q · filed 2020-08-13 | -$415.00K 10-Q · filed 2020-08-13 | -$264.00K derived: sum of 3 quarters · filed 2020-08-13 | -$147.00K derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | $23.00K 10-Q · filed 2020-05-14 | $174.00K derived: sum of 2 quarters · filed 2020-05-14 | $291.00K derived: sum of 3 quarters · filed 2020-05-14 | $290.00K derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | $151.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $268.00K derived: sum of 2 quarters · filed 2020-03-27 | $267.00K derived: sum of 3 quarters · filed 2020-03-27 | $267.00K 10-K · filed 2020-03-27 |
| 2018-09-30 | $117.00K 10-Q · filed 2019-11-13 | $116.00K derived: sum of 2 quarters · filed 2019-11-13 | $116.00K 10-Q · filed 2019-11-13 | |
| 2018-06-30 | -$1.00K 10-Q · filed 2019-08-09 | -$1.00K 10-Q · filed 2019-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |